Alyssa Vitali LPCA
Counselor/Therapist
460 WILSON AVE VERSAILLES KY, 40383About
Alyssa Vitali is a counselor in VERSAILLES, KY. Alyssa evaluates patients using many different procedures, in order to determine what treatments must be carried out in order to properly assess their symptoms. Counselors provide consultation for each patient and their families.
Provider Details
Alyssa Vitali LPCA's Practice location
Alyssa Vitali LPCA's reviews
Write ReviewRecommended Articles
- 5 Signs That You Are an Extrovert
Extroverts are described as being sociable, talkative, friendly, enthusiastic, outgoing, and action-oriented. Although these characteristics are positive, sometimes, extroverts are also associated with negative impressions, such as being attention seekers, often distracted, and have a hard time...
- Canadian Doctors Say: Money Should Go to Nurses and Lower Healthcare Costs
More than 700 Canadian physicians, medical students, specialists and resident doctors signed an online petition stating they won’t take the $700 million in raises provided to them by the provincial government after last month's negotiations.Refreshing! It’s not very often that anyone gives back...
- Separation Anxiety in Children: Symptoms, Causes, Diagnosis and More
It’s normal for young children to feel anxious when they're separated from a loved one. However, when this fear occurs in a child above six years of age, is intense, and persists for more than four weeks, the child may have separation anxiety disorder.What is Separation Anxiety Disorder?Separation...
- Lose Weight Without Fad Diets
According to a new study published in, American Journal of Preventive Medicine, eating less fat, getting more exercise, and discussing a weight loss plan with a doctor is the most effective way to lose weight. This study focused on the methods followed by successful dieters to lose the extra weight...
- Sleep Apnea's Impact on a Patient's Heart
Though sleep apnea often causes atrial fibrillation, there is a lack of awareness.Neglecting sleep disorders is easy. They are widely prevalent, and yet poorly diagnosed and an underrated risk factor for many health conditions. Sleep apnea, one of the most common sleep disorders touches 3-7% of the...
- FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis
On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...